Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: Phase 2 clinical KEYNOTE-059 trial

Simple item page
dc.contributor.authorFuchs, C. S.
dc.contributor.authorDoi, T.
dc.contributor.authorJang, R. W.
dc.contributor.authorMuro, K.
dc.contributor.authorSatoh, T.
dc.contributor.authorMachado, M.
dc.contributor.authorSun, W.
dc.contributor.authorJalal, S. I.
dc.contributor.authorShah, M. A.
dc.contributor.authorGarrido S., Marcelo
dc.contributor.authorMetges, J. P.
dc.date.accessioned2021-05-31T03:44:57Z
dc.date.available2021-05-31T03:44:57Z
dc.date.issued2018
dc.fuente.origenConveris
dc.identifier.doi10.1001/jamaoncol.2018.0013
dc.identifier.eissn2374-2445
dc.identifier.issn2374-2437
dc.identifier.urihttps://doi.org/10.1001/jamaoncol.2018.0013
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/60038
dc.issue.numeroNo. 5
dc.language.isoen
dc.nota.accesoContenido parcial
dc.revistaJAMA Oncologyes_ES
dc.rightsacceso restringido
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.otherNeoplasias esofágicases_ES
dc.subject.otherAnticuerpos monoclonaleses_ES
dc.subject.otherCáncer gástricoes_ES
dc.titleSafety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: Phase 2 clinical KEYNOTE-059 triales_ES
dc.typeartículo
dc.volumenVol. 4
sipa.codpersvinculados7260
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer Phase 2 clinical KEYNOTE-059 trial.pdf
Size:
3.64 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas